Analyticon Biotechnologies
Private Company
Total funding raised: $12.5M
Overview
Analyticon Biotechnologies is a well-established, mid-sized German diagnostics company with over 45 years of operational history. It has built a strong global footprint, particularly in urine diagnostics, with a portfolio ranging from manual test strips to automated urine sediment and hematology analyzers. The company's business model combines direct sales with a significant OEM partnership network, emphasizing product reliability, quality, and comprehensive customer support. Recent product launches indicate a focus on expanding its automated and connected diagnostic solutions for laboratory and point-of-care settings.
Technology Platform
Portfolio of in-vitro diagnostic systems for urine analysis and hematology, including manual test strips, automated urine strip readers, automated urine sediment analyzers, and integrated data connectivity solutions.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Operates in the highly competitive global IVD market, competing with large multinational corporations (e.g., Roche, Abbott, Siemens) in some segments and numerous specialized and low-cost manufacturers in others. Differentiation is based on product reliability, quality, customer support, and a hybrid direct/OEM business model.